丁香实验_LOGO
登录
提问
我要登录
|免费注册
点赞
收藏
wx-share
分享

Analyzing Binding Data

互联网

1544
  • Abstract
  • Table of Contents
  • Materials
  • Figures
  • Literature Cited

Abstract

 

Measuring the rate and extent of radioligand binding provides information on the number of binding sites, and their affinity and accessibility of these binding sites for various drugs. This unit explains how to design and analyze such experiments. Curr. Protoc. Neurosci. 52:7.5.1?7.5.65. © 2010 by John Wiley & Sons, Inc.

Keywords: binding; radioligand; radioligand binding; Scatchard plot; receptor binding; competitive binding curve; IC50; Kd; Bmax; nonlinear regression; curve fitting; fluorescence

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Binding Theory
  • Saturation Binding Experiments
  • Competitive Binding Experiments
  • Kinetic Binding Experiments
  • Two Binding Sites
  • Agonist Binding
  • Use of Fluorescence or Other Spectroscopic Methods in Binding Experiments
  • Basic Protocol 1: Fluorescence Saturation Binding of BODIPY FL‐GTPγS to GαO
  • Analyzing Data Using Nonlinear Regression
  • Evaluating Results of Nonlinear Regression
  • Comparing Treatment Groups
  • Calculations with Radioactivity
  • Analyzing Data with GraphPad Prism
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Fluorescence Saturation Binding of BODIPY FL‐GTPγS to GαO

  Materials
  • Ligand (BODIPY‐FL‐GTPγS; Invitrogen) stock solution: 10 µl of 100 µM frozen in 1 mM DTT
  • G protein (Gα o ) stock solution: 20 µM snap frozen in HED buffer
  • Binding buffer: HED buffer (see below) containing 10 mM MgCl 2
  • HED buffer: 50 mM HEPES, pH 8, containing 1 mM EDTA and 1 mM DTT
  • Competing ligand (e.g., 100 µM GTPγS)
  • Costar 3915 black 96‐well microplate
  • Fluorescence plate reader
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

  •   Figure 7.5.1 Occupancy at equilibrium. The fraction of receptors occupied by a ligand at equilibrium depends on the concentration of the ligand compared to its K d .
    View Image
  •   Figure 7.5.2 Examples of nonspecific binding. (A ) [3 H]Mesulergine binding to serotonin receptors has low nonspecific binding (<25% of total binding at the highest concentrations). (B ) [3 H]Meproadifen binding to the ion channel of nicotinic receptors has high nonspecific binding (>50%).
    View Image
  •   Figure 7.5.3 Total binding, specific binding, and nonspecific binding for a saturation binding experiment.
    View Image
  •   Figure 7.5.4 Displaying results as a Scatchard plot. (A ) Specific binding as a function of free radioligand. (B ) Transformation of Scatchard data to a plot.
    View Image
  •   Figure 7.5.5 Why Scatchard plots (though useful for displaying data) should not be used for analyzing data. (A ) Experimental data with best‐fit curve determined by nonlinear regression. (B ) Scatchard plot of the data. The solid line corresponds to the B max and K d determined by nonlinear regression in panel A. The dashed line was determined by linear regression of transformed data in panel B. The results of linear regression of the Scatchard plot are not the most accurate values for B max ( x intercept) or K d (negative reciprocal of the slope).
    View Image
  •   Figure 7.5.6 Sample saturation binding experiment. The ligand binding to angiotensin receptors in a membrane preparation was measured. Total and nonspecific binding are shown.
    View Image
  •   Figure 7.5.7 These data are the same as those shown in Figure . The left panel (A ) fits a curve through the specific binding data (Strategy 1). The right panel (B ) globally fits total and nonspecific binding data (Strategy 3).
    View Image
  •   Figure 7.5.8 Scatchard transformation of the data from Figure . The solid line was created (as explained in the text) from the best‐fit values of B max and K d determined from nonlinear regression. This is the correct line to show on a Scatchard plot. The dashed line was determined by linear regression of the Scatchard‐transformed data. It is shown here for comparison only; it is not informative or helpful.
    View Image
  •   Figure 7.5.9 Schematic of a competitive binding experiment.
    View Image
  •   Figure 7.5.10 Steepness of a competitive binding curve. This graph shows the results at equilibrium when radioligand and competitor bind to the same binding site. The curve will descend from 90% binding to 10% binding over an 81‐fold increase in competitor concentration.
    View Image
  •   Figure 7.5.11 Example of a competitive binding experiment. Yohimbine competes for radioligand binding to α2 receptors on membranes.
    View Image
  •   Figure 7.5.12 Example of homologous competitive binding experiment. The hot and cold ligands are identical.
    View Image
  •   Figure 7.5.13 Examples of slope factors. The slope factor quantifies the steepness of the curve, and is determined by nonlinear regression of competitive binding data. It is not the same as the slope of the curves at the midpoints.
    View Image
  •   Figure 7.5.14 Schematic of a dissociation kinetic experiment.
    View Image
  •   Figure 7.5.15 Schematic of a dissociation kinetic experiment shown on a log scale. The y axis plots the natural log of specific binding.
    View Image
  •   Figure 7.5.16 Schematic of an association kinetic experiment.
    View Image
  •   Figure 7.5.17 Schematic of observed association rate constants as a function of radioligand concentration. Higher concentrations of radioligand equilibrate more quickly. The slope of the line equals the association rate constant ( k on ); the y intercept is the dissociation rate constant ( k off ).
    View Image
  •   Figure 7.5.18 Saturation binding to two classes of receptors. The two receptor types are present in equal quantities, but have K d values that differ by a factor of ten. (A ) Binding to the two individual receptor types are shown as dashed curves. The sum (observed experimentally) is shown as a solid curve. It is not obviously biphasic. (B ) Scatchard transformation. The curvature of the overall Scatchard plot (solid) is subtle, and it would be easy to miss the curvature if the data were scattered. Note that the Scatchard plots for the individual receptors (dashed) are not asymptotes of the two‐site Scatchard plot (solid).
    View Image
  •   Figure 7.5.19 Two‐site competitive binding curve. The radioligand binds identically to two kinds of receptors, but these two receptors have a ten‐fold difference in affinity for the competitor. The curve is shallow, but not obviously biphasic.
    View Image
  •   Figure 7.5.20 Discriminating between binding to two (or more) binding sites (A ) and negative cooperativity (B ). With negative cooperativity, dissociation will be faster when initiated by adding excess unlabeled ligand than when initiated by infinite dilution.
    View Image
  •   Figure 7.5.21 The solid curve shows the fit to an equation describing competition for a single class of receptors. The dashed curve shows the fit to an equation describing competition for binding to two classes of receptors.
    View Image
  •   Figure 7.5.22 Schematic of agonist competition for binding to a receptor linked to a G protein. In the absence of GTP (left) the curve is shallow (and in this extreme case, biphasic). In the presence of GTP (or an analog) the curve is shifted to the right and is steeper.
    View Image
  •   Figure 7.5.23 Models for agonist binding to receptors linked to G proteins. H, hormone or agonist; R, receptor; G, G protein.
    View Image
  •   Figure 7.5.24 Fluorescence intensity at various concentrations of receptor as a function of added ligand concentration. The upper left panel shows the total fluorescence intensity. The upper right panel converts to nM bound. The lower left panel normalizes the curve for each receptor concentration so they all plateau at the same maximum, and compares the EC50 values. The lower right panel zooms in on the lowest ligand concentrations.
    View Image
  •   Figure 7.5.25 Fluorescence saturation curves for binding of BODIPY‐FL‐GTPγS to three different G protein alpha subunits. Binding was measured as described in the with a 20 nM final concentration of Gαo and Gαs , incubated at room temperature for 20 min. For Gαi1 , a final concentration of 100 nM was used with incubations for 60 min at 30°C (reprinted with permission from McEwen et al., ).
    View Image
  •   Figure 7.5.26 Fluorescence polarization measurements of αMSH binding. Fluorescent ligand (0.5 nM BODIPY‐NDP‐αMSH) was incubated with increasing amounts of membrane containing the indicated concentrations of MC5 receptor. Fluorescence polarization was measured and plotted versus concentration of added receptor. Data from Nosjean et al. ().
    View Image
  •   Figure 7.5.27 Fluorescence polarization measurements of αMSH binding with varying ligand. Membranes containing 1 nM MC5 receptor were incubated with increasing amounts of fluorescent ligand (BODIPY‐NDP‐αMSH). Fluorescence polarization was measured and plotted versus concentration of added ligand. As indicated in the text, the fraction of bound ligand (and the polarization) is highest at the low ligand concentrations. These data were fitted using NLLSQ analysis with Equation , with a fixed value of R T = 1.0 nM (Nosjean et al., ). Although the concentration of ligand at which the polarization falls to a half‐maximal value is about 2 nM, the calculated K d is 0.43 nM due to ligand depletion that occurs because R T > K d .
    View Image
  •   Figure 7.5.28 A dose‐response curve with data collected over a narrow range of concentrations. When a nonlinear regression program tries to fit the top and bottom plateaus as well as the EC50 and slope, the resulting confidence intervals are very wide. Since there is no data to define zero and one hundred, the program will be very uncertain about the EC50 . If the nonlinear regression program is told to set the top and bottom plateaus to constant values (from controls), then it can determine the EC50 with precision.
    View Image
  •   Figure 7.5.29 A dose response curve with no data in the middle of the curve. Since there are no data points in the middle of the curve, the best‐fit value of the EC50 will be uncertain with a wide confidence interval.
    View Image
  •   Figure 7.5.30 Residuals. The top panel (A ) graphs dissociation kinetic data. The bottom panel (B ) shows the residuals (i.e., the y axis plots the distance between the point and the curve from the top panel).
    View Image
  •   Figure 7.5.31 What is a false minimum? A nonlinear regression program stops when making any small change to a parameter will worsen the fit and thus raise the sum of squares. In rare cases, this may happen at a false minimum rather than the true best fit value.
    View Image
  •   Figure 7.5.32 Counting error. With more counts, the fractional counting error decreases. The x axis shows the number of radioactive decays actually counted (counts per minute times number of minutes).
    View Image

Videos

Literature Cited

Literature Cited
   Cheng, Y. and Prusoff, W.H. 1973. Relationship between the inhibition constant (Ki) and the concentration of an inhibitor that causes a 50% inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099‐3108.
   Gordon, G.W., Berry, G., Liang, X.H., Levine, B., and Herman, B. 1998. Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. Biophys. J. 74:2702‐2713.
   Kenakin, T. 2006. A Pharmacology Primer, Second Edition: Theory, Applications, and Methods. Academic Press, San Diego.
   Lakowicz, J.R. 2006. Principles of Fluorescence Spectroscopy, 3rd ed., Springer, New York.
   Limbird, L.E. 2004. Cell Surface Receptors: A Short Course in Theory and Methods, 3rd ed., Springer, New York.
   McEwen, D.P., Gee, K.R., Kang, H.C., and Neubig, R.R. 2001. Fluorescent BODIPY‐GTP analogs: Real‐time measurement of nucleotide binding to G proteins. Anal. Biochem. 291:109‐117.
   Motulsky, H.J. and Mahan, L.C. 1984. The kinetics of competitive radioligand binding predicted by the law of mass action. Mol. Pharmacol. 25:1‐9.
   Munson, P.J. and Rodbard, D. 1980. Ligand: A versatile computerized approach to characterization of ligand binding systems. Anal. Biochem. 107:220‐239.
   Neubig, R.R. and Cohen, J.B. 1979. Equilibrium binding of [3H]tubocurarine and [3H]acetylcholine by Torpedo postsynaptic membranes: Stoichiometry and ligand interactions. Biochemistry 18:5464‐5475.
   Nosjean, O., Souchaud, S., Deniau, C., Geneste, O., Cauquil, N., and Boutin, J.A. 2006. A simple theoretical model for fluorescence polarization binding assay development. J. Biomol. Screen. 11:949‐958.
   Roman, D.L., Talbot, J.N., Roof, R.A., Sunahara, R.K., Traynor, J.R., and Neubig, R.R. 2007. Identification of small‐molecule inhibitors of RGS4 using a high‐throughput flow cytometry protein interaction assay. Mol Pharmacol. 71:169‐175.
   Rosenthal, H.E. 1967. A graphic method for the determination and presentation of binding parameters in complex systems. Anal. Biochem. 20:525‐532.
   Swillens, S. 1995. Interpretation of binding curves obtained with high receptor concentrations: Practical aid for computer analysis. Mol. Pharmacol. 47:1197‐1203.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library
 
提问
扫一扫
丁香实验小程序二维码
实验小助手
丁香实验公众号二维码
扫码领资料
反馈
TOP
打开小程序